Trial Profile
Pharmacodynamics and pharmacokinetics of single ascending doses of ONO 5334 in postmenopausal women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2012
Price :
$35
*
At a glance
- Drugs ONO 5334 (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Ono Pharmaceutical
- 23 Jul 2012 New trial record